2701563-03-1

2701563-03-1 structure

Name: EGFR-IN-31
Chemical Name: EGFR-IN-31
CAS Number: 2701563-03-1
Molecular Formula: C₃₂H₃₆FN₇O₂
Molecular Weight: 569.67
Create Date: 2022-05-23 20:53:02
Modify Date: 2024-04-12 00:07:11
EGFR-IN-31 is a potent inhibitor of EGFR. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-31 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185298A1, compound 2)[1].

Name	EGFR-IN-31

Description	EGFR-IN-31 is a potent inhibitor of EGFR. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-31 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185298A1, compound 2)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
References	[1]. Jiaqi Hu, et al. Egfr tyrosine kinase inhibitors and their uses. Patent WO2021185298A1.

Molecular Formula	C₃₂H₃₆FN₇O₂
Molecular Weight	569.67